News
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...
4d
The Print on MSNFat-busting blockbuster drug Wegovy launched in India, in pre-filled pens that can be self-administeredDanish pharma giant Novo Nordisk’s announcement comes months after the launch of another top selling obesity drug Mounjaro in India by US based pharma giant Eli Lilly & Company.
The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025 ...
2d
The Print on MSNIn battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on otherIndia's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.
Wegovy 2.4mg is administered through a once-weekly FlexTouch pen, and is suitable for adults with obesity (BMI ≥30 kg/m²), or overweight (BMI ≥27 to <30 kg/m²) with at least one weight-related ...
Factor Zepbound for weight loss and weight management Wegovy for weight loss and weight management; Form: liquid solution in two forms, each for injection under your skin: • single-use pen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results